Açaí, Euterpe oleracea Cancer Research Results

Acai, EO, Açaí, Euterpe oleracea: Click to Expand ⟱
Features:

Açaí (Euterpe oleracea) — A dark purple fruit of the Amazonian açaí palm, classified as a polyphenol-rich functional food and botanical food source rather than a single pharmacologically defined compound. Standard names include açaí, acai berry and E. oleracea (EO). Its principal bioactive constituents include cyanidin-3-glucoside, cyanidin-3-rutinoside, proanthocyanidins, flavonoids, phenolic acids, and oleic- and linoleic-acid-rich lipids. Anthocyanin-rich pulp and catechin-rich seed extracts differ substantially in composition and biological activity. Experimental research emphasizes colorectal chemoprevention, anti-inflammatory effects, reduced tumor-cell proliferation and apoptosis induction. No clinical anticancer efficacy has been established.

Primary mechanisms (ranked):

  1. Inflammatory signaling suppression: ↓ NF-κB, TNF-α, IL-1β, IL-6 and COX-2 in selected experimental systems; attenuation of inflammation-associated tumor promotion.
  2. Mitochondrial apoptosis induction: ↓ Bcl-2 and survivin, ↑ cytochrome c release and caspase-3 cleavage in susceptible cancer cells, favoring intrinsic apoptotic signaling.
  3. Antiproliferative activity: ↓ tumor-cell growth and proliferation markers including PCNA and Ki-67 in experimental colorectal cancer models.
  4. Specificity protein signaling: ↓ Sp-family transcription factors and associated Bcl-2, survivin and VEGF expression in SW-480 colon cancer cells.
  5. Oxidative stress modulation: ↓ experimentally induced ROS and oxidative injury in selected cellular systems; systemic antioxidant effects are modest and biomarker-dependent.
  6. Adhesion and migration signaling: ↓ ICAM-1 and VCAM-1 expression in colon cancer cells; isolated cyanidin-3-rutinoside can reduce cancer-cell motility at experimental concentrations.
  7. Tumor-associated immune modulation: ↓ IL-6 and ↑ IFN-γ following administration of catechin-rich açaí seed extract in a mouse tumor model.

Bioavailability / PK relevance: Intact anthocyanins have low systemic availability following oral açaí consumption. In a human crossover study, total anthocyanins measured as cyanidin-3-glucoside equivalents reached approximately 2.32 ng/mL after pulp and 1.14 ng/mL after juice, with peak concentrations near 2 hours. Extensive metabolism and microbial transformation contribute to exposure to downstream phenolic metabolites. Processing, drying, storage and the fruit fraction used can substantially modify bioactive composition.

In-vitro vs systemic exposure relevance: Reported colon cancer cell effects from polyphenolic extracts at 5–20 mg/L cannot be equated with concentrations of intact circulating anthocyanins following ordinary consumption. The isolated cyanidin-3-rutinoside concentration of 25 µM used in a migration experiment greatly exceeds typical circulating intact anthocyanin concentrations. Local gastrointestinal exposure and microbial metabolites may be more relevant than systemic exposure for colorectal effects.

Clinical evidence status: Preclinical anticancer evidence includes cell-culture experiments and several rodent tumor-prevention studies, particularly colorectal models. Small human studies and a randomized placebo-controlled trial have assessed metabolic, inflammatory and oxidative-stress biomarkers, with mixed outcomes. No established human cancer-prevention or cancer-treatment benefit, clinically validated anticancer dose, or proven chemotherapy-adjunct indication exists. Açaí is a food, not an approved anticancer medication.

Açaí — Mechanistic Effects in Cancer and Normal Cells

Rank Pathway / Axis Cancer Cells Normal Cells TSF Primary Effect Notes / Interpretation
1 NF-κB / Inflammatory Cytokines ↓ NF-κB signaling; ↓ TNF-α, IL-1β, IL-6 (model-dependent) ↓ inflammatory cytokine production in activated macrophages R/G Anti-inflammatory and chemopreventive activity Supported by colorectal cancer cell studies and inflammation-associated animal tumor models. Effects vary with extract and experimental system.
2 Mitochondrial Apoptosis / Caspase-3 ↓ Bcl-2; ↑ cytochrome c; ↑ cleaved caspase-3; ↑ apoptotic signaling Relative preservation of viability in CCD-18Co fibroblasts at tested extract concentrations G Intrinsic apoptotic cell death Demonstrated with açaí polyphenolic extract in SW-480 colon cancer cells. Effects should not be generalized to all cancers or ordinary oral pulp exposure.
3 Cell Proliferation / PCNA / Ki-67 ↓ proliferation; ↓ PCNA; ↓ Ki-67 (model-dependent) ↔ viability in selected nonmalignant cell assays G Suppression of tumor-cell proliferation Supported by colon cancer cell experiments and rodent colorectal carcinogenesis studies.
4 Sp Transcription Factors / Survivin / Bcl-2 ↓ Sp-family activity; ↓ survivin; ↓ Bcl-2 Not established G Reduced survival signaling and increased apoptosis susceptibility Reported in SW-480 colon cancer cells with polyphenolic extract. Mechanistic specificity requires confirmation in additional models.
5 VEGF / Angiogenic Signaling ↓ VEGF expression (model-dependent) Not established G Potential reduction in proangiogenic signaling VEGF downregulation has been reported in vitro; direct inhibition of tumor angiogenesis in humans has not been demonstrated.
6 ROS / Oxidative Stress ↓ induced ROS (context-dependent) ↓ oxidative stress biomarkers in selected experimental and human settings P/R/G Antioxidant and cellular stress modulation Reduced H2O2-induced ROS was observed in colon cancer cells. Human biomarker responses are inconsistent. Açaí does not require increased ROS to induce apoptosis in the principal colon cancer study.
7 COX-2 / Myeloperoxidase / Colonic Inflammation ↓ inflammation-associated tumor promotion ↓ COX-2 and inflammatory activation in experimental macrophage systems G Suppression of inflammatory microenvironment Especially relevant to chemically induced and colitis-associated colorectal cancer models.
8 ICAM-1 / VCAM-1 / Cell Adhesion ↓ ICAM-1; ↓ VCAM-1 Not established G Reduced adhesion-associated inflammatory signaling Observed in SW-480 colon cancer cells. Direct prevention of metastatic dissemination remains unproven.
9 Cancer Cell Migration / Cyanidin-3-rutinoside ↓ RKO colon cancer cell motility (high concentration only) Not established G Potential antimigratory effect Observed using isolated cyanidin-3-rutinoside at 25 µM. This exposure substantially exceeds typical plasma concentrations after dietary açaí consumption.
10 IL-6 / IFN-γ / Tumor Immune Response ↓ tumor-promoting inflammatory environment (model-dependent) ↓ IL-6; ↑ IFN-γ in a murine tumor model G Immunomodulation Reported with catechin-rich seed extract, especially at 400 mg/kg in mice. Seed-extract findings cannot be attributed directly to commercial pulp products.
11 PPARα / Dlc1 / Akt3 Gene Expression ↑ selected negative regulators of proliferation and inflammation Not established G Potential regulation of tumor development Gene expression changes were observed in a colitis-associated rat model. Increased Akt3 expression should not be interpreted as generalized inhibition of PI3K/AKT signaling.
12 Clinical Translation Constraint Strong dependence on extract composition and cell-culture exposure Food-level consumption generally tolerated; long-term concentrated-extract safety less characterized — Uncertain human anticancer relevance Low intact-anthocyanin bioavailability, extensive metabolism, differences between pulp and seed extracts, high experimental exposures and absence of cancer efficacy trials limit therapeutic interpretation.

TSF: P: 0–30 min R: 30 min–3 hr G: >3 hr. Time-scale categories are approximate mechanistic classifications, not uniformly measured experimental onset times.



Scientific Papers found: Click to Expand⟱
9256- Acai, EO,    Pro-apoptotic activities of polyphenolics from açai (Euterpe oleracea Martius) in human SW-480 colon cancer cells
- in-vitro, CRC, HT-29 - in-vitro, Colon, SW480
TumCG↓, *toxicity↓, selectivity↑, ROS↓, NF-kB↓, ICAM-1↓, VCAM-1↓, Sp1/3/4↓, Bcl-2↓, VEGF↓, survivin↓, cl‑Cyt‑c↑, cl‑Casp3↑, PARP1↓,
9257- Acai, EO,    Açai (Euterpe oleracea Mart.) feeding attenuates dimethylhydrazine-induced rat colon carcinogenesis
- in-vivo, CRC, NA
Dose↝, eff↑, TumNum↓, Ki-67↓,
9258- Acai, EO,    Açaí Berries Inhibit Colon Tumorigenesis in Azoxymethane/Dextran Sulfate Sodium-Treated Mice
- in-vivo, CRC, NA
Risk↓, *MPO↓, *TNF-α↓, *IL1β↓, *IL6↓, *PCNA↓, *Bcl-2↓, *cl‑Casp3↓, *COX2/PTGS2?,
9259- Acai, EO,    Antitumor Effect of Açaí (Euterpe oleracea Mart.) Seed Extract in LNCaP Cells and in the Solid Ehrlich Carcinoma Model
- vitro+vivo, Pca, LNCaP
Ingr↝, eff↝, Dose↝, TumVol↓, necrosis↑, IL6↓, IFN-γ↓,
9260- Acai, EO,    Anticancer potential, molecular mechanisms and toxicity of Euterpe oleracea extract (açaí): A systematic review
- Review, Var, NA
Dose↝, Risk↓, chemoPv↑, TumCP↓, Inflam↓, toxicity↓, IFN-γ↑, IL5↓, IL8↓, MPO↓, TNF-α↓, IL1β↓, IL6↓, PCNA↓, Ki-67↓, Casp3↑, Bcl-2↓, toxicity↓,
9261- Acai, EO,    Pharmacokinetics of anthocyanins and antioxidant effects after the consumption of anthocyanin-rich acai juice and pulp (Euterpe oleracea Mart.) in human healthy volunteers
- Study, Nor, NA
*Dose?, *BioAv↝, *eff↑,
9262- Acai, EO,    Phytochemical and nutrient composition of the freeze-dried amazonian palm berry, Euterpe oleraceae mart. (acai)
- Analysis, Nor, NA
*Ingr↝, *Ingr↝, *Ingr↝,

Showing Research Papers: 1 to 7 of 7

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 7

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

MPO↓, 1,   ROS↓, 1,  

Cell Death(tgid=5) ⓘ

Bcl-2↓, 2,   Casp3↑, 1,   cl‑Casp3↑, 1,   cl‑Cyt‑c↑, 1,   necrosis↑, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

Sp1/3/4↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

PARP1↓, 1,   PCNA↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

Ki-67↓, 2,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Ki-67↓, 2,   TumCG↓, 1,   TumCP↓, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

VCAM-1↓, 1,   VEGF↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ICAM-1↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 1,   IL1β↓, 1,   IL5↓, 1,   IL6↓, 2,   IL8↓, 1,   Inflam↓, 1,   NF-kB↓, 1,   TNF-α↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

Dose↝, 3,   eff↑, 1,   eff↝, 1,   selectivity↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

IL6↓, 2,  

Functional Outcomes(tgid=23) ⓘ

chemoPv↑, 1,   Risk↓, 2,   toxicity↓, 2,   TumNum↓, 1,   TumVol↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 1,  
Total Targets: 38

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1) ⓘ

MPO↓, 1,  

Cell Death(tgid=5) ⓘ

Bcl-2↓, 1,   cl‑Casp3↓, 1,  

DNA Damage & Repair(tgid=10) ⓘ

PCNA↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

COX2/PTGS2?, 1,   IL1β↓, 1,   IL6↓, 1,   TNF-α↓, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↝, 1,   Dose?, 1,   eff↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

IL6↓, 1,  

Functional Outcomes(tgid=23) ⓘ

toxicity↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 3,  
Total Targets: 14

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:520  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page